Antigenic differences among B16 melanoma variants selected for their differing abilities to metastasize: a possible mechanism for effective adjuvant immunotherapy.
作者信息
Steele G, Wang B S, Ghavamzadah G, Fallon M, Richie J, Wilson R E, Mannick J A
出版信息
J Surg Oncol. 1980;15(1):71-83. doi: 10.1002/jso.2930150112.
PMID:6158632
Abstract
摘要
相似文献
1
Antigenic differences among B16 melanoma variants selected for their differing abilities to metastasize: a possible mechanism for effective adjuvant immunotherapy.
J Surg Oncol. 1980;15(1):71-83. doi: 10.1002/jso.2930150112.
2
3
4
Prevention of death from metastases by immune RNA therapy.
Science. 1978 Oct 6;202(4363):59-60. doi: 10.1126/science.694519.
5
Immunogenicity and cross-protection among B16 melanoma variants with differing proclivities to metastasize.
J Surg Oncol. 1981;18(4):381-8. doi: 10.1002/jso.2930180407.
6
[The inhibitory effect of batroxobin against the lung metastasis of the B16-F10 melanoma cells implanted in the mice in relation to the activity of the NK cell].
Nihon Ika Daigaku Zasshi. 1988 Apr;55(2):201-8. doi: 10.1272/jnms1923.55.201.
7
The control of tumor metastasis.
Results Probl Cell Differ. 1980;11:233-40. doi: 10.1007/978-3-540-38267-6_30.
8
[Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
Gan To Kagaku Ryoho. 1985 Mar;12(3 Pt 1):510-5.
9
Immune RNA in tumor immunology.
Ann N Y Acad Sci. 1979;332:196-206. doi: 10.1111/j.1749-6632.1979.tb47113.x.
10
Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity.
Br J Cancer. 1977 Oct;36(4):453-60. doi: 10.1038/bjc.1977.214.
引用本文的文献
1
Immunoselection of tumor variants resistant to antibody-mediated cytotoxicity. Their immunologic and metastatic characterization.
Cancer Immunol Immunother. 1982;14(2):124-31. doi: 10.1007/BF00200180.
Zotero 插件